Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)โข Click on a phase to view related trials
Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations
- Conditions
- Rabies ExposureImmunocompromisedChronic Disease
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Liaoning Chengda Biotechnology CO., LTD
- Target Recruit Count
- 180
- Registration Number
- NCT07120464
- Locations
- ๐จ๐ณ
Luohu District People's Hospital., Shenzhen, Canton, China
Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis
- Conditions
- Japanese Encephalitis Vaccine
- Interventions
- Biological: Japanese Encephalitis Vaccine (Vero Cell), InactivatedBiological: Japanese Encephalitis Vaccine, Live
- First Posted Date
- 2025-02-13
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Liaoning Chengda Biotechnology CO., LTD
- Target Recruit Count
- 600
- Registration Number
- NCT06825312
- Locations
- ๐จ๐ณ
Jiashan County Center for Disease Control and Prevention, Jiaxing, Zhejiang, China
๐จ๐ณPinghu Center For Disease Control and Prevention, Jiaxing, Zhejiang, China
๐จ๐ณDongyang Center for Disease Control and Prevention, Jinhua, Zhejiang, China
Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas
- Conditions
- Japanese Encephalitis
- Interventions
- Biological: Liaoning Chengda Inactivated Japanese Encephalitis Vaccine
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Liaoning Chengda Biotechnology CO., LTD
- Target Recruit Count
- 250
- Registration Number
- NCT06678373
- Locations
- ๐จ๐ณ
Liaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning, China
Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization
- Conditions
- Japanese Encephalitis
- First Posted Date
- 2024-04-18
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Liaoning Chengda Biotechnology CO., LTD
- Target Recruit Count
- 15357
- Registration Number
- NCT06372665
- Locations
- ๐จ๐ณ
Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China
Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)
- Conditions
- MeaslesRubellaMumpsJapanese Encephalitis
- Interventions
- Biological: Vero cell-drived inactive Japanese encephalitis vaccineBiological: Measles-Mumps-Rubella Vaccine
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Liaoning Chengda Biotechnology CO., LTD
- Target Recruit Count
- 408
- Registration Number
- NCT06331702
- Locations
- ๐จ๐ณ
Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China